SAN FRANCISCO, August 06, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in ECLIPSE 3. All three trials in the Company’s registrational ...

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

A viral rumour has caused panic about a supposed six-minute global blackout during a solar eclipse on August 2, 2025. Vedic astrology and Hindu panchang clearly state that no solar eclipse will ...

ECLIPSE is a registrational program to evaluate the safety and efficacy of tobevibart in combination with elebsiran in patients with chronic hepatitis delta (CHD).

The TIOBE Index is an indicator of which programming languages are most popular within a given month. Top 10 programming languages in August 2025 ...

Java defies the hype cycle, thriving at 30 with unmatched enterprise trust, modern AI integration, and a vibrant, global developer community.